<?xml version="1.0" encoding="UTF-8"?>
<questel-patent-document lang="en" date-produced="20180805" produced-by="Questel" schema-version="3.23" file="US06180105B2.xml">
  <bibliographic-data lang="en">
    <publication-reference publ-desc="Granted patent as second publication">
      <document-id>
        <country>US</country>
        <doc-number>06180105</doc-number>
        <kind>B2</kind>
        <date>20010130</date>
      </document-id>
      <document-id data-format="questel">
        <doc-number>US6180105</doc-number>
      </document-id>
    </publication-reference>
    <original-publication-kind>B2</original-publication-kind>
    <application-reference family-id="26310127" extended-family-id="17764506">
      <document-id>
        <country>US</country>
        <doc-number>09282763</doc-number>
        <kind>A</kind>
        <date>19990331</date>
      </document-id>
      <document-id data-format="questel">
        <doc-number>1999US-09282763</doc-number>
      </document-id>
      <document-id data-format="questel_Uid">
        <doc-number>18222816</doc-number>
      </document-id>
    </application-reference>
    <language-of-filing>en</language-of-filing>
    <language-of-publication>en</language-of-publication>
    <priority-claims>
      <priority-claim kind="national" sequence="1">
        <country>US</country>
        <doc-number>28276399</doc-number>
        <kind>A</kind>
        <date>19990331</date>
        <priority-active-indicator>Y</priority-active-indicator>
      </priority-claim>
      <priority-claim data-format="questel" sequence="1">
        <doc-number>1999US-09282763</doc-number>
      </priority-claim>
      <priority-claim kind="national" sequence="2">
        <country>GB</country>
        <doc-number>9620292</doc-number>
        <kind>A</kind>
        <date>19960928</date>
        <priority-linkage-type>T</priority-linkage-type>
        <priority-active-indicator>Y</priority-active-indicator>
      </priority-claim>
      <priority-claim data-format="questel" sequence="2">
        <doc-number>1996GB-0020292</doc-number>
      </priority-claim>
    </priority-claims>
    <dates-of-public-availability>
      <publication-of-grant-date>
        <date>20010130</date>
      </publication-of-grant-date>
    </dates-of-public-availability>
    <classifications-ipcr>
      <classification-ipcr sequence="1">
        <text>A61K  36/282       20060101A I20080531RMEP</text>
        <ipc-version-indicator>
          <date>20060101</date>
        </ipc-version-indicator>
        <classification-level>A</classification-level>
        <section>A</section>
        <class>61</class>
        <subclass>K</subclass>
        <main-group>36</main-group>
        <subgroup>282</subgroup>
        <classification-value>I</classification-value>
        <generating-office>
          <country>EP</country>
        </generating-office>
        <classification-status>R</classification-status>
        <classification-data-source>M</classification-data-source>
        <action-date>
          <date>20080531</date>
        </action-date>
      </classification-ipcr>
      <classification-ipcr sequence="2">
        <text>C07D 493/20        20060101A I20051008RMEP</text>
        <ipc-version-indicator>
          <date>20060101</date>
        </ipc-version-indicator>
        <classification-level>A</classification-level>
        <section>C</section>
        <class>07</class>
        <subclass>D</subclass>
        <main-group>493</main-group>
        <subgroup>20</subgroup>
        <classification-value>I</classification-value>
        <generating-office>
          <country>EP</country>
        </generating-office>
        <classification-status>R</classification-status>
        <classification-data-source>M</classification-data-source>
        <action-date>
          <date>20051008</date>
        </action-date>
      </classification-ipcr>
    </classifications-ipcr>
    <classification-national>
      <country>US</country>
      <main-classification>
        <text>424725000</text>
        <class>424</class>
        <subclass>725000</subclass>
      </main-classification>
      <further-classification sequence="1">
        <text>514450000</text>
        <class>514</class>
        <subclass>450000</subclass>
      </further-classification>
      <further-classification sequence="2">
        <text>549348000</text>
        <class>549</class>
        <subclass>348000</subclass>
      </further-classification>
    </classification-national>
    <classifications-ecla>
      <classification-ecla sequence="1">
        <text>C07D-493/20</text>
        <section>C</section>
        <class>07</class>
        <subclass>D</subclass>
        <main-group>493</main-group>
        <subgroup>20</subgroup>
      </classification-ecla>
      <classification-ecla sequence="2">
        <text>A61K-036/282</text>
        <section>A</section>
        <class>61</class>
        <subclass>K</subclass>
        <main-group>36</main-group>
        <subgroup>282</subgroup>
      </classification-ecla>
    </classifications-ecla>
    <patent-classifications>
      <patent-classification sequence="1">
        <classification-scheme office="EP" scheme="CPC">
          <date>20130101</date>
        </classification-scheme>
        <classification-symbol>C07D-493/20</classification-symbol>
        <section>C</section>
        <class>07</class>
        <subclass>D</subclass>
        <main-group>493</main-group>
        <subgroup>20</subgroup>
        <symbol-position>F</symbol-position>
        <classification-value>I</classification-value>
        <classification-status>B</classification-status>
        <classification-data-source>H</classification-data-source>
        <action-date>
          <date>20180609</date>
        </action-date>
      </patent-classification>
      <patent-classification sequence="2">
        <classification-scheme office="EP" scheme="CPC">
          <date>20130101</date>
        </classification-scheme>
        <classification-symbol>A61K-036/282</classification-symbol>
        <section>A</section>
        <class>61</class>
        <subclass>K</subclass>
        <main-group>36</main-group>
        <subgroup>282</subgroup>
        <symbol-position>L</symbol-position>
        <classification-value>I</classification-value>
        <classification-status>B</classification-status>
        <classification-data-source>H</classification-data-source>
        <action-date>
          <date>20180609</date>
        </action-date>
      </patent-classification>
      <patent-classification sequence="3">
        <classification-scheme office="EP" scheme="CPC">
          <date>20180101</date>
        </classification-scheme>
        <classification-symbol>Y02A-050/411</classification-symbol>
        <section>Y</section>
        <class>02</class>
        <subclass>A</subclass>
        <main-group>50</main-group>
        <subgroup>411</subgroup>
        <symbol-position>L</symbol-position>
        <classification-value>A</classification-value>
        <classification-status>B</classification-status>
        <classification-data-source>H</classification-data-source>
        <action-date>
          <date>20180409</date>
        </action-date>
      </patent-classification>
    </patent-classifications>
    <number-of-claims>30</number-of-claims>
    <exemplary-claim>1</exemplary-claim>
    <figures>
      <number-of-drawing-sheets>0</number-of-drawing-sheets>
      <number-of-figures>0</number-of-figures>
      <image-key data-format="questel">US6180105</image-key>
    </figures>
    <invention-title format="original" lang="en" id="title_en">Method for producing an extract containing artemesinin</invention-title>
    <references-cited>
      <citation srep-phase="examiner">
        <patcit num="1">
          <text>SCHULTZ WILLIAM G</text>
          <document-id>
            <country>US</country>
            <doc-number>3477856</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US3477856</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="examiner">
        <patcit num="2">
          <text>PANZNER FRANK, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>4554170</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US4554170</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="examiner">
        <patcit num="3">
          <text>SCHUETZ ERWIN, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>4632837</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US4632837</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="examiner">
        <patcit num="4">
          <text>DUBOC SORAYA, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>4985265</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US4985265</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="examiner">
        <patcit num="5">
          <text>WEATHERS PAMELA J, et al</text>
          <document-id>
            <country>US</country>
            <doc-number>5413928</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>US5413928</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="examiner">
        <patcit num="6">
          <text>GUANGZHOU MEDICINE INDUSTRY IN</text>
          <document-id>
            <country>CN</country>
            <doc-number>1095381</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>CN1095381</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="examiner">
        <patcit num="7">
          <text>ESSENTIAL NUTRITION LTD</text>
          <document-id>
            <country>GB</country>
            <doc-number>2317612</doc-number>
            <kind>A</kind>
          </document-id>
          <document-id data-format="questel">
            <doc-number>GB2317612</doc-number>
          </document-id>
        </patcit>
      </citation>
      <citation srep-phase="examiner">
        <nplcit num="1">
          <text>Kohler et al. J. Chromatogr. vol 785, pp. 353-360, 1997.</text>
        </nplcit>
      </citation>
      <citation srep-phase="examiner">
        <nplcit num="2">
          <text>Kohler et al. Phytochem. Anal. vol. 8, No. 5, pp. 223-227, abstract enclosed, 1997.</text>
        </nplcit>
      </citation>
      <citation srep-phase="examiner">
        <nplcit num="3">
          <text>Khanan et al. Khim-Farm. Zh. vol. 2, No. 2, pp. 40-44, 1968.</text>
        </nplcit>
      </citation>
      <citation srep-phase="examiner">
        <nplcit num="4">
          <text>Sigma Chemical Catalog, p. 135 (#A 5430), 1994.</text>
        </nplcit>
      </citation>
      <citation srep-phase="examiner">
        <nplcit num="5">
          <text>Quellette, R. Intro. to General, Organic, and Biological Chem., 2nd ed., p. 545, 1988.</text>
        </nplcit>
      </citation>
      <citation srep-phase="examiner">
        <nplcit num="6">
          <text>The Condensed Chem Dictionary, 10th ed., pp. 598 (lactone), 916 (sesquiterpene), 1000 (terpene), 1981.</text>
        </nplcit>
      </citation>
      <citation srep-phase="examiner">
        <nplcit num="7">
          <text>Grimmett, C. Chemistry and Industry-Food Processing. vol.. 10, pp. 359-362, 1981.</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="8">
          <text>Chemical Abstract No.335344f-Ge et al., Supercritical extraction of arteanniun from Artemisia annua., May 19, 1993.</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="9">
          <text>Hubert et al., Fluid Extraction of Hops, Spices &amp; Tobacco with Supercritical Gases, Agnew. Chem. Int. Ed. Engl., vol. 17, pp. 710-715, 1978.</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="10">
          <text>Moyler, Estraction of Essential Oils with Carbon Dioxide, 23nd Int'l Symposium on Essential Oils, Scotland Sep. 9-12, 1992.</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="11">
          <text>Ronyai et al., Production of Plant Extracts by Supercritical Extraction, Olaj, Szappan, Kozmet, vol. 45, (Special Issue), 1996.</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="12">
          <text>CN 1095381 A (GE et al.) Abstract only., 1994.</text>
        </nplcit>
      </citation>
      <citation srep-phase="applicant">
        <nplcit num="13">
          <text>Chem Abstr. (23:335344f, 1993.</text>
        </nplcit>
      </citation>
    </references-cited>
    <parties>
      <applicants>
        <applicant data-format="original" app-type="applicant" sequence="1">
          <addressbook lang="en">
            <orgname>Essential Nutrition Ltd.</orgname>
            <address>
              <address-1>Brough, GB</address-1>
              <city>Brough</city>
              <country>GB</country>
            </address>
          </addressbook>
          <nationality>
            <country>GB</country>
          </nationality>
        </applicant>
        <applicant data-format="questel" app-type="applicant" sequence="2">
          <addressbook lang="en">
            <orgname>ESSENTIAL NUTRITION</orgname>
          </addressbook>
          <nationality>
            <country>GB</country>
          </nationality>
        </applicant>
      </applicants>
      <inventors>
        <inventor data-format="original" sequence="1">
          <addressbook lang="en">
            <name>Wheatley, Gary William</name>
            <address>
              <address-1>Hull, GB</address-1>
              <city>Hull</city>
              <country>GB</country>
            </address>
          </addressbook>
          <nationality>
            <country>GB</country>
          </nationality>
        </inventor>
        <inventor data-format="original" sequence="2">
          <addressbook lang="en">
            <name>Chapman, Thomas Brian</name>
            <address>
              <address-1>Brough, GB</address-1>
              <city>Brough</city>
              <country>GB</country>
            </address>
          </addressbook>
          <nationality>
            <country>GB</country>
          </nationality>
        </inventor>
      </inventors>
      <agents>
        <agent sequence="1" rep-type="agent">
          <addressbook lang="en">
            <orgname>Jenkens &amp; Gilchrist A Professional Corporation</orgname>
          </addressbook>
        </agent>
      </agents>
    </parties>
    <examiners>
      <primary-examiner>
        <name>Tate, Christopher</name>
      </primary-examiner>
    </examiners>
    <lgst-data>
      <lgst-status>LAPSED</lgst-status>
    </lgst-data>
  </bibliographic-data>
  <abstract format="original" lang="en" id="abstr_en">
    <p id="P-EN-00001" num="00001">
      <br/>
      A method of preparation of an artemisinin extract comprising the steps of extraction of Artemisia annua with liquid carbon dioxide and allowing the carbon dioxide to evaporate from the resultant mixture.
    </p>
  </abstract>
  <description format="original" lang="en" id="desc_en">
    <p num="1">
      This invention relates to the production of a novel extract from Artemisia annua which contains high levels of the known anti-malarial active Artemisinin.
      <br/>
      The invention also relates to a method of producing such an extract.
    </p>
    <p num="2">
      Artemisia annua has been used in China for many centuries for the treatment of malaria.
      <br/>
      Research in the 1970s by Chinese scientists confirmed the efficacy of preparations of Artemisia annua in the treatment of malaria, including the most severe and life threatening form of the disease known as cerebral malaria, caused by infection with the Plasmodium falciparum parasite.
      <br/>
      The main chemical constituent of Artemisia responsible for this pharmacological activity was identified as the unusual bridged peroxy sesquiterpene structure originally named "Qinghaosu" but now known as artemisinin.
      <br/>
      The structure of artemisinin is given below:  (Chemical Structure image '1' not included in text)
    </p>
    <p num="3">
      Clinical studies on artemisinin and semi-synthetic derivatives such as artemether have confirmed the efficacy of this type of compound in the treatment of malaria.
      <br/>
      Artemisinin lacks the nitrogen containing heterocyclic ring that is common to the standard anti-malarials currently used such as the aminoquinolines (quinine, chloroquine, primaquine, etc.) The problem of resistance and cross-resistance that is now beginning to seriously limit the effectiveness of these drugs is not observed for artemisinin.
      <br/>
      For example, artemisinin has been found to be effective against chloroquine resistant strains of Plasmodium falciparum.
    </p>
    <p num="4">
      Artemisinin has recently been prepared synthetically but such is the complexity of the molecule that there is no large scale economical synthetic route.
      <br/>
      This has been recognized by the vigorous research effort directed towards the synthesis of much simpler analogues of artemisinin.
    </p>
    <p num="5">
      Chinese researchers in their earlier studies favored extracts of Artemisia produced using non-polar organic solvents such as diethyl ether or more commonly, petroleum ether.
      <br/>
      However, these have the drawbacks that the artemisinin content was quite low and that it was difficult to completely remove trace levels of the solvent to produce a pharmaceutically acceptable product.
      <br/>
      The extraction process uses large quantities of organic solvent which must either be disposed of or recycled.
    </p>
    <p num="6">
      In recent years, the use of liquefied carbon dioxide extraction has been applied to the isolation of pharmaceutical actives from plant materials.
      <br/>
      This technique has been used on an industrial scale for over two decades for the extraction of flavor principles from hops and other herbs and spices.
      <br/>
      It has the advantage over extraction with conventional organic solvents that the extraction medium is readily and completely removed simply by depressurizing the extraction apparatus, thus allowing the liquid carbon dioxide to vaporize into the atmosphere.
      <br/>
      Thus, problems of waste solvent disposal and trace solvent contamination of finished product are eliminated.
      <br/>
      The selectivity of liquid carbon dioxide is generally superior to organic solvents of comparable polarity such as ethyl acetate or petroleum ether.
    </p>
    <p num="7">According to a first aspect of the present invention, a method of preparation of an artemisinin extract comprises the steps of extraction of Artemisia annua with solvent comprising liquid carbon dioxide and allowing the carbon dioxide to evaporate from the resultant mixture.</p>
    <p num="8">According to a second aspect of the present invention, there is provided an Artemisia annua extract containing more than 10% by weight of artemisinin, the extract not containing any residual organic solvent.</p>
    <p num="9">
      A co-solvent may be employed, for example a polar hydroxylic solvent such as C1 to C4 alcohol, preferably ethanol.
      <br/>
      An amount of co-solvent of 5 to 20%, preferably 10% by weight may be employed.
    </p>
    <p num="10">The resultant residual extract may have a high artemisinin content without any traces of residual non-hydroxylic solvent.</p>
    <p num="11">Preferred methods involve extraction at a pressure of 1500 to 4500 psi (100 to 310 bars), preferably about 1500 psi (100 bars) and at a temperature in the region of 20 to 50 (degree)  C., preferably 25 to 30 (degree)  C. Use of sub-critical carbon dioxide without any co-solvent is preferred.</p>
    <p num="12">The invention is further described by means of example but not in any limitative sense.</p>
    <heading>EXAMPLE</heading>
    <p num="13">
      Roughly ground aerial parts of the herb Artemisia annua were packed into a pressure vessel.
      <br/>
      A volume of liquid carbon dioxide at the ratio of approximately 5 ml of liquid carbon dioxide per 1 g of herbaceous matter was allowed to pass through the raw material at a rate of approximately 0.9 ml/min. The liquid carbon dioxide was then collected, the pressure released and the carbon dioxide allowed to vent to the atmosphere.
      <br/>
      The residual extract in the collection vessel was an oil or semi-solid dependent on the exact extraction conditions.
    </p>
    <p num="14">The following range of extraction conditions were employed:</p>
    <p num="15">
      --
      <br/>
      --                                     CO-           % YIELD
      <br/>
      -- SAMPLE      PRESSURE      TEMP      SOLVENT       (w/w)       % ARTEMESININ
      <br/>
      -- Art 1       1500 psi      27 (degree)  C. None          1.1%         14%
      <br/>
      -- Art 2       1500 psi      27 (degree)  C. 10% Ethanol   3.2%        3.3%
      <br/>
      -- Art 3       4500 psi      50 (degree)  C. None          0.2%        2.0%
      <br/>
      -- Art 4       4500 psi      50 (degree)  C. 10% Ethanol   3.7%        1.0%
    </p>
    <p num="16">Extraction conditions of 1500 psi and 27 (degree)  C. are equivalent to the use of subcritical liquid carbon dioxide and 4500 psi at 50 (degree)  C. is equivalent to the use of supercritical carbon dioxide.</p>
    <p num="17">
      An estimate of the artemisinin content was made by semi-quantitative TLC.
      <br/>
      The use of subcritical carbon dioxide with no added organic co-solvent yielded optimum results with an approximate artemisinin content of &gt;10% by weight being obtained for extract Art 1.
      <br/>
      All other extraction conditions yielded much lower artemisinin contents of approximately 3 % or less.
    </p>
    <p num="18">By way of comparison, a standard petroleum ether extract of Artemisia was prepared and the artemisinin content found to be 5.2% by the semi-quantitative TLC method for an overall yield of extract of 2.9%.</p>
    <p num="19">The artemisinin content of the raw material used was estimated by TLC to be 0.15% w/w which is in agreement with the previously published range of 0.01 to 0.6% w/w for Artemisia annua samples.</p>
  </description>
  <claims format="original" lang="en" id="claim_en">
    <claim num="1">
      <claim-text>What is claimed is:</claim-text>
      <claim-text>1.</claim-text>
      <claim-text>A method of preparation of an artemisinin extract comprising the steps of extrtacting ground aerial parts of Artemisia annua with a solvent comprising subcritical liquid carbon dioxide and allowing the carbon dioxide to evaporate from the reultant mixture to directly isolate an extract of at least 10% by weight artemisinin that does not contain residual solvent.</claim-text>
    </claim>
    <claim num="2">
      <claim-text>2. The method of claim 1, wherein the solvent comprises a mixture of liquid carbon dioxide and a polar hydroxylic solvent.</claim-text>
    </claim>
    <claim num="3">
      <claim-text>3. The method of claim 2, wherein the hydroxylic solvent is a C1-4 alcohol.</claim-text>
    </claim>
    <claim num="4">
      <claim-text>4. The method of claim 3, wherein the hydroxylic solvent is ethanol.</claim-text>
    </claim>
    <claim num="5">
      <claim-text>5. The method of claim 2, wherein the amount of hydroxylic solvent is 5 to 20% by weight.</claim-text>
    </claim>
    <claim num="6">
      <claim-text>6. The method of claim 3, wherein the amount of hydroxylic solvent is 5 to 20% by weight.</claim-text>
    </claim>
    <claim num="7">
      <claim-text>7. The method of claim 4, wherein the amount of hydroxylic solvent is 5 to 20% by weight.</claim-text>
    </claim>
    <claim num="8">
      <claim-text>8. The method of claim 2, wherein the amount of hydroxylic solvent is 10% by weight.</claim-text>
    </claim>
    <claim num="9">
      <claim-text>9. The method of claim 3, wherein the amount of hydroxylic solvent is 10% by weight.</claim-text>
    </claim>
    <claim num="10">
      <claim-text>10. The method of claim 4, wherein the amount of hydroxylic solvent is 10% by weight.</claim-text>
    </claim>
    <claim num="11">
      <claim-text>11. The method of claim 1, wherein the extraction is carried out at a pressure of 1500 psi.</claim-text>
    </claim>
    <claim num="12">
      <claim-text>12. The method of claim 2, wherein the extraction is carried out at a pressure of 1500 psi.</claim-text>
    </claim>
    <claim num="13">
      <claim-text>13. The method of claim 3, wherein the extraction is carried out at a pressure of 1500 psi.</claim-text>
    </claim>
    <claim num="14">
      <claim-text>14. The method of claim 4, wherein the extraction is carried out at a pressure of 1500 psi.</claim-text>
    </claim>
    <claim num="15">
      <claim-text>15. The method of claim 5, wherein the extraction is carried out at a pressure of 1500 psi.</claim-text>
    </claim>
    <claim num="16">
      <claim-text>16. The method of claim 6, wherein the extraction is carried out at a pressure of 1500 psi.</claim-text>
    </claim>
    <claim num="17">
      <claim-text>17. The method of claim 7, wherein the extraction is carried out at a pressure of 1500 psi.</claim-text>
    </claim>
    <claim num="18">
      <claim-text>18. The method of claim 8, wherein the extraction is carried out at a pressure of 1500 psi.</claim-text>
    </claim>
    <claim num="19">
      <claim-text>19. The method of claim 9, wherein the extraction is carried out at a pressure of 1500 psi.</claim-text>
    </claim>
    <claim num="20">
      <claim-text>20. The method of claim 10, wherein the extraction is carried out at a pressure of 1500 psi.</claim-text>
    </claim>
    <claim num="21">
      <claim-text>21. The method of claim 11, wherein the extraction is carried out at a temperature of 25 to 30 (degree)  C.</claim-text>
    </claim>
    <claim num="22">
      <claim-text>22. The method of claim 12, wherein the extraction is carried out at a temperature of 25 to 30 (degree)  C.</claim-text>
    </claim>
    <claim num="23">
      <claim-text>23. The method of claim 13, wherein the extraction is carried out at a temperature of 25 to 30 (degree)  C.</claim-text>
    </claim>
    <claim num="24">
      <claim-text>24. The method of claim 14, wherein the extraction is carried out at a temperature of 25 to 30 (degree)  C.</claim-text>
    </claim>
    <claim num="25">
      <claim-text>25. The method of claim 15, wherein the extraction is carried out at a temperature of 25 to 30 (degree)  C.</claim-text>
    </claim>
    <claim num="26">
      <claim-text>26. The method of claim 16, wherein the extraction is carried out at a temperature of 25 to 30 (degree)  C.</claim-text>
    </claim>
    <claim num="27">
      <claim-text>27. The method of claim 17, wherein the extraction is carried out at a temperature of 25 to 30 (degree)  C.</claim-text>
    </claim>
    <claim num="28">
      <claim-text>28. The method of claim 18, wherein the extraction is carried out at a temperature of 25 to 30 (degree)  C.</claim-text>
    </claim>
    <claim num="29">
      <claim-text>29. The method of claim 19, wherein the extraction is carried out at a temperature of 25 to 30 (degree)  C.</claim-text>
    </claim>
    <claim num="30">
      <claim-text>30. The method of claim 20, wherein the extraction is carried out at a temperature of 25 to 30 (degree)  C.</claim-text>
    </claim>
  </claims>
</questel-patent-document>